Please use this identifier to cite or link to this item:
http://hdl.handle.net/11690/3350
Authors: | Antonio, Eduardo Cheuiche Meireles, Mariana Rost Bragatte, Marcelo Alves de Souza Vieira, Gustavo Fioravanti |
Title: | Viral immunogenic footprints conferring T cell cross-protection to SARS-CoV-2 and its variants |
Keywords: | T-cell epitopes;Structural analysis;Cross-reactivity;Cellular response;Immuno informatics;SARS-CoV-2;Coronaviruses |
Issue Date: | 2022 |
Publisher: | Frontiers |
Citation: | ANTONIO, E. C. et al. Viral immunogenic footprints conferring T cell cross-protection to SARS-CoV-2 and its variants. Frontiers in Immunology, v. 13, p. 1, 2022. Disponível em: https://www.frontiersin.org/articles/10.3389/fimmu.2022.931372/full. Acesso em: 05 out. 2022. |
Abstract: | COVID-19 brought scenes from sci-fi movies into real life. Infected individuals include asymptomatic cases to severe disease leading to death, suggesting the involvement of the genetic constitution of populations and pathogens contributing to differential individuals’ outcomes. To investigate shared immunogenic features between SARS-CoV-2 targets and other coronaviruses, we modeled their peptides in 3D structures of HLA-A*02:01 (pMHC), comparing their molecular surfaces These structures were also compared with a panel of epitopes from unrelated viruses, looking for potential triggers conferring cross-protection in uninfected individuals. As expected, SARS-CoV 1 and 2 peptides share molecular and physicochemical features, providing an explanation for the verified experimental immunogenicity among them. Surprisingly, even discordant sequences from human coronaviruses 229E, OC43 and epitopes from unrelated viruses involved in endemic human infections exhibit similar fingerprints of immunogenicity with SARS-CoV-2 peptides. The same approach indicates a conserved CD8+ T cell recognition between Wuhan SARS-CoV-2 sequences and altered peptides from Variants of Concern. Examination of structural data over epitope sequence analysis here could explain how previous infections may produce a heterologous immunity response in a global scale against emergent diseases such as Covid-19, mitigating its full lethal potential, and paves the way for the development of wide spectrum vaccine development. |
Appears in Collections: | Artigo de Periódico (PPGSDH) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
antonio.etal.pdf | Open Access | 4,84 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.